News | Artificial Intelligence | October 24, 2019

Medical AI software company and U.S. cancer center operator partner to further advance early detection and characterization of various cancers with artificial intelligence

Enlitic Announces Strategic Partnership With Select Healthcare Solutions

October 24, 2019 — Artificial intelligence (AI) software developer Enlitic Inc. announced it has signed a strategic partnership with Select HealthCare Solutions, a developer, owner and operator of cancer centers across the U.S. As part of the agreement, Enlitic will receive access to Select Healthcare’s high-quality, anonymized patient data –– data that will further tune Enlitic’s predictive models for early cancer detection. In turn, Select HealthCare will receive access to Enlitic’s AI software technology and will directly contribute to the development of future Enlitic products in radiology, oncology and pathology.

Enlitic’s deep learning models have demonstrated potential for the early detection of malignancies. In an independent validation study from 2017, Enlitic's algorithm was found to detect lung nodules with 91.1 percent sensitivity at time of biopsy, operating on par with state-of-the-art computer-aided detection (CAD), but with much higher specificity. Furthermore, the algorithm was shown to detect malignancies 6 and 12 months before biopsy, and reliably caught cancerous nodules 17.5 months earlier than when a biopsy was ordered.

Enlitic’s partnership with Select HealthCare adds to Enlitic’s global partnership roster of healthcare and technology companies, including Capitol Health, a leading Australian healthcare provider; Marubeni Corp., a Japan-based global conglomerate; and Konica Minolta, a multinational technology company also based in Japan.

“Enlitic’s diagnostic AI software is crucial to improving patient care in the future and we are excited to join the company’s list of world-class partners by providing comprehensive multimodal data that will help revolutionize how cancer is detected and treated,” said Matthew Cutler, president and CEO of Select HealthCare Solutions. “We believe that our clinical experience in treating complex cancers, combined with Enlitic’s best-in-class technologies and experience in early disease detection, will ultimately help save millions of lives.”

For more information: www.enlitic.com


Related Content

News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | Ultrasound Imaging

Oct. 19, 2026 – GE HealthCare has introduced LOGIQ Focus, a new addition to its LOGIQ family of general imaging ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 8, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., has announced new findings published in ...

Time October 13, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Radiation Oncology

Sept. 23, 2026 — GE HealthCare has announced a new collaboration with a research team at Mass General Brigham to explore ...

Time October 02, 2026
arrow
Feature | Digital Pathology | Kyle Hardner

As recently as a decade ago, pathology technology was expected to become more expensive, larger and more precise. Yet in ...

Time October 02, 2026
arrow
News | Digital Pathology

Sept. 24, 2026 — Leica Biosystems,has added two Paige digital pathology AI-enabled products from Tempus to its Aperio AI ...

Time September 25, 2026
arrow
News | RSNA

Sept. 22, 2026 — The Radiological Society of North America (RSNA) is now offering a certificate program that equips ...

Time September 24, 2026
arrow
News | Ultrasound Imaging

Sept. 16, 2026 — Ultrasound AI, Inc., a developer of artificial intelligence for medical imaging with a focus on ...

Time September 17, 2026
arrow
Subscribe Now